BK vs BSX · P/E 17, $94.14B cap vs P/E 20, rev $10.65B
The Bank of New York Mellon Corporation (BK) versus Boston Scientific Corp (BSX) — a side-by-side from cached financials, not a winner call.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
BK does not have a complete income-statement cache yet.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
BK currently screens at market cap $94.14B and trailing P/E 17.0. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Not investment advice. Open the BK and BSX stock pages for the full models.
Not investment advice.